| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
ARVN
Arvinas Holding Company
|
Aug 05, 2026 | HOLD |
Buy
+237.5% avg upside
28 analysts
|
$11.00
30.89% Upside
|
+0.0% | · |
|
ORIC
Oric Pharmaceuticals
|
Aug 04, 2026 | BUY |
Strong Buy
+82.5% avg upside
19 analysts
|
$25.00
93.45% Upside
|
+0.0% | · |
|
PYXS
Pyxis Oncology
|
Aug 03, 2026 | BUY |
Strong Buy
+134.1% avg upside
14 analysts
|
$12.00
283.36% Upside
|
· | · |
|
INCY
Incyte
|
Jul 29, 2026 | HOLD |
Buy
-10.4% avg upside
47 analysts
|
$116.00
3.25% Downside
|
-5.7% | · |
|
CLDX
Celldex
|
Jul 29, 2026 | BUY |
Strong Buy
-0.2% avg upside
28 analysts
|
$72.00
75.42% Upside
|
+4.1% | · |
|
TRAX
First Tracks Biotherapeutics Inc
|
Jul 28, 2026 | BUY |
Strong Buy
+3.1% avg upside
7 analysts
|
$55.00
17.10% Upside
|
+14.2% | · |
|
ARGX
Argenx Se
|
Jul 23, 2026 | BUY |
Strong Buy
-9.9% avg upside
47 analysts
|
$1350.00
55.55% Upside
|
-8.7% | · |
|
VRDN
Viridian Therapeutics
|
Jul 20, 2026 | BUY |
Strong Buy
+68.0% avg upside
32 analysts
|
$31.00
47.19% Upside
|
+11.3% | · |
|
RYTM
Rhythm Pharmaceuticals
|
Jul 16, 2026 | BUY |
Strong Buy
+12.0% avg upside
19 analysts
|
$155.00
40.03% Upside
|
-6.5% | · |
|
ANNX
Annexon Biosciences
|
Jul 15, 2026 | BUY |
Strong Buy
+162.5% avg upside
14 analysts
|
$27.00
402.80% Upside
|
-21.6% | · |
|
QTTB
Q32 Bio
|
Jul 14, 2026 | BUY |
Strong Buy
+265.9% avg upside
24 analysts
|
$66.00
300.20% Upside
|
-10.7% | · |
|
NRIX
Nurix Therapeutics
|
Jul 14, 2026 | HOLD |
Strong Buy
+28.3% avg upside
28 analysts
|
$25.00
0.55% Downside
|
+1.0% | · |
|
XFOR
X4 Pharmaceuticals
|
Jul 10, 2026 | BUY |
Strong Buy
+474.6% avg upside
16 analysts
|
$11.00
165.04% Upside
|
-2.7% | · |
|
ALMS
Alumis Inc.
|
Jul 01, 2026 | BUY |
Strong Buy
+41.3% avg upside
11 analysts
|
$51.00
88.07% Upside
|
+1.8% | · |
|
SEPN
Septerna, Inc.
|
Jun 29, 2026 | BUY |
Strong Buy
+18.0% avg upside
12 analysts
|
$48.00
23.82% Upside
|
-1.3% | · |
|
GLUE
Monte Rosa Therapeutics
|
Jun 24, 2026 | BUY |
Strong Buy
+52.8% avg upside
15 analysts
|
$29.00
85.82% Upside
|
-22.3% | · |
|
ASND
Ascendis Pharma
|
Jun 17, 2026 | BUY |
Strong Buy
+13.0% avg upside
24 analysts
|
$326.00
33.49% Upside
|
+5.7% | · |
|
IMVT
Immunovant
|
May 21, 2026 | BUY |
Strong Buy
-0.4% avg upside
24 analysts
|
$45.00
14.63% Upside
|
+13.2% | · |
|
ATYR
aTyr Pharma
|
May 18, 2026 | HOLD |
Buy
+1521.0% avg upside
17 analysts
|
$1.00
89.02% Upside
|
-7.1% | · |
|
CCCC
C4 Therapeutics
|
May 13, 2026 | BUY |
Strong Buy
+395.4% avg upside
19 analysts
|
$10.00
176.33% Upside
|
-1.9% | · |
|
KYTX
Kyverna Therapeutics, Inc.
|
May 12, 2026 | BUY |
Strong Buy
+257.3% avg upside
7 analysts
|
$33.00
332.01% Upside
|
-23.9% | · |
|
BBIO
BridgeBio Pharma
|
May 09, 2026 | BUY |
Strong Buy
+13.0% avg upside
34 analysts
|
$98.00
19.53% Upside
|
+27.5% | · |
|
ALXO
ALX Oncology Holdings
|
Mar 19, 2026 | BUY |
Strong Buy
+818.9% avg upside
11 analysts
|
$5.00
160.43% Upside
|
-10.1% | · |
|
KYMR
Kymera Therapeutics
|
Mar 02, 2026 | BUY |
Strong Buy
-1.5% avg upside
37 analysts
|
$116.00
10.03% Upside
|
+14.8% | · |
|
IRON
Disc Medicine
|
Mar 02, 2026 | BUY |
Strong Buy
+11.1% avg upside
21 analysts
|
$79.00
0.08% Upside
|
+17.1% | · |
|
EXEL
Exelixis
|
Feb 11, 2026 | HOLD |
Buy
-24.9% avg upside
34 analysts
|
$35.00
38.20% Downside
|
+6.8% | · |
|
ALNY
Alnylam Pharma
|
Jan 20, 2026 | HOLD |
Strong Buy
+43.0% avg upside
51 analysts
|
$376.00
64.30% Upside
|
-35.9% | · |
|
ANAB
AnaptysBio
|
Dec 16, 2025 | BUY |
Strong Buy
+31.7% avg upside
26 analysts
|
$81.00
47.37% Upside
|
+83.2% | · |
|
CQP
Cheniere Energy Partners
|
Dec 16, 2025 | SELL |
Sell
-19.2% avg upside
24 analysts
|
$56.00
12.69% Downside
|
-28.8% | · |
|
LQDA
Liquidia Technologies
|
Oct 17, 2025 | BUY |
Strong Buy
-29.2% avg upside
15 analysts
|
$31.00
65.22% Downside
|
+296.7% | · |
|
PTCT
PTC Therapeutics
|
Oct 17, 2025 | BUY |
Buy
+17.0% avg upside
29 analysts
|
$73.00
5.47% Upside
|
+6.8% | · |
|
TECX
Tectonic Therapeutic
|
Oct 17, 2025 | BUY |
Strong Buy
+91.0% avg upside
24 analysts
|
$101.00
241.58% Upside
|
+59.7% | · |
|
STRO
Sutro Biopharma
|
Aug 12, 2025 | HOLD |
Strong Buy
+53.9% avg upside
20 analysts
|
$30.00
19.46% Upside
|
+209.9% | · |
|
CABA
Cabaletta Bio
|
Aug 08, 2025 | HOLD |
Strong Buy
+410.9% avg upside
16 analysts
|
$2.00
26.20% Downside
|
+92.7% | · |
|
ZYME
Zymeworks
|
Aug 07, 2025 | HOLD |
Strong Buy
+37.4% avg upside
25 analysts
|
$14.00
40.39% Downside
|
+80.7% | · |
|
ZNTL
Zentalis Pharmaceuticals
|
Aug 06, 2025 | HOLD |
Buy
+186.8% avg upside
18 analysts
|
$5.00
0.93% Upside
|
+243.5% | · |
|
TSE:WEED
Canopy Growth
|
Dec 06, 2021 | SELL |
Hold
+1276.8% avg upside
23 analysts
|
$11.26
765.98% Upside
|
· | · |
|
SMG
Scotts Miracle-Gro Company
|
Dec 06, 2021 | BUY |
Strong Buy
+26.7% avg upside
11 analysts
|
$180.00
172.19% Upside
|
-60.7% | · |
|
EQ
Equillium
|
Jun 13, 2021 | BUY |
Strong Buy
+324.4% avg upside
16 analysts
|
$12.00
447.94% Upside
|
-66.3% | · |
|
HRTX
Heron Therapeutics
|
May 13, 2021 | BUY |
Strong Buy
+5274.2% avg upside
21 analysts
|
$27.00
5248.71% Upside
|
· | · |
|
URGN
Urogen Pharma
|
May 13, 2021 | BUY |
Strong Buy
-2.2% avg upside
16 analysts
|
$30.00
35.48% Downside
|
-61.3% | · |
|
RNAC
Cartesian Therapeutics
|
May 13, 2021 | HOLD |
Strong Buy
+279.7% avg upside
19 analysts
|
$3.00
64.04% Downside
|
-75.1% | · |
|
LKFT
Lakefront Biotherapeutics
|
May 09, 2021 | HOLD |
Buy
+304.2% avg upside
24 analysts
|
$97.00
271.89% Upside
|
-23.1% | · |
|
MDGL
Madrigal Pharmaceuticals
|
May 06, 2021 | HOLD |
Strong Buy
-1.9% avg upside
33 analysts
|
$130.00
74.73% Downside
|
-49.0% | · |
|
DBVT
DBV Technologies SA - American
|
May 03, 2021 | HOLD |
Buy
+69.1% avg upside
15 analysts
|
$6.00
57.96% Downside
|
-79.3% | · |
|
AMRN
Amarin
|
Apr 29, 2021 | HOLD |
Buy
-41.4% avg upside
18 analysts
|
$6.00
58.33% Downside
|
-48.7% | · |
|
VKTX
Viking Therapeutics
|
Apr 28, 2021 | BUY |
Strong Buy
+117.0% avg upside
31 analysts
|
$13.00
61.20% Downside
|
-62.0% | · |
|
FR:IVA
Inventiva
|
Mar 05, 2021 | BUY |
Strong Buy
+350.6% avg upside
6 analysts
|
$16.48
325.23% Upside
|
-12.4% | · |
|
IVA
Inventiva
|
Mar 05, 2021 | BUY |
Strong Buy
+240.3% avg upside
17 analysts
|
$19.00
302.54% Upside
|
-20.1% | · |
|
GB:0QW0
arGEN X
|
Mar 04, 2021 | HOLD |
Strong Buy
-16.7% avg upside
24 analysts
|
$288.82
61.53% Downside
|
-3.7% | · |
|
NL:LKFT
Galapagos
|
Feb 19, 2021 | HOLD |
Sell
+129.1% avg upside
16 analysts
|
$96.00
319.48% Upside
|
-16.7% | · |
|
FR:GNFT
Genfit
|
Sep 30, 2020 | BUY |
Strong Buy
+113.5% avg upside
5 analysts
|
$11.00
21.80% Downside
|
-14.7% | · |
|
VNDA
Vanda
|
Jul 10, 2020 | HOLD |
Strong Buy
+300.5% avg upside
13 analysts
|
— | +78.6% | · |
|
PCRX
Pacira Pharmaceuticals
|
Jul 10, 2020 | HOLD |
Buy
+54.3% avg upside
21 analysts
|
— | -1.5% | · |
|
ZVRA
Zevra Therapeutics
|
Apr 02, 2018 | BUY |
Strong Buy
+116.6% avg upside
15 analysts
|
$13.00
23.47% Upside
|
-72.9% | · |
|
TRVN
Trevena
|
Mar 22, 2018 | BUY |
Buy
+1402152.2% avg upside
11 analysts
|
— | · | · |
|
PRGO
Perrigo Company
|
Mar 05, 2018 | BUY |
Buy
+424.0% avg upside
20 analysts
|
$98.00
638.47% Upside
|
-39.2% | · |
|
TEVA
Teva Pharmaceutical
|
Feb 08, 2018 | HOLD |
Buy
-13.6% avg upside
39 analysts
|
— | -2.2% | · |
|
TPST
Tempest Therapeutics
|
Nov 09, 2017 | HOLD |
Buy
+2280.7% avg upside
18 analysts
|
— | · | · |
|
VTRS
Viatris
|
Oct 03, 2017 | HOLD |
Buy
+31.7% avg upside
21 analysts
|
— | +12.5% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.